The Akt-mTOR pathway is dysregulated in multiple animal models of monogenic causes of ASD, including fragile X mental retardation [42], Rett Syndrome [43] and tuberous sclerosis [44], whereas IGF-1 ligands may improve neurodevelopmental symptoms in Rett Syndrome [45]. This evidence concerns the gene AKT1 and Rett syndrome.